... Centre for Alcohol Policy Research (CAPR), La Trobe University, found reducing ... Centre for Alcohol Policy Research (CAPR) is an innovative, world-class ... out more visit http://www.capr.edu.au ... 56% 13 Jan 21 Heavy drinkers consuming more than half of all alcohol ... s Centre for Alcohol Policy and Research (CAPR), and funded by the Foundation for Alcohol ... FARE Chief Executive, Michael Thorn said the CAPR study reinforces the important role of regulating ... 51% 22 Apr 21 Alcohol tax reform needed ... La Trobe Centre for Alcohol Policy Research (CAPR) health economist Dr Jason (Heng) Jiang said ... moderate drinkers ($178.40 vs $20.90). CAPR researchers also found 62 per cent of ... 51% 21 Apr 21 Research: Alcohol and tobacco policies can reduce cancer deaths ... Australian cancer death rates, new research shows. The La Trobe Centre for Alcohol Policy Research (CAPR) has led the first study into how public health policies on alcohol and tobacco ... 41% 21 Apr 21 Cardiac stem cells from young hearts could rejuvenate old hearts, new study shows ... is provided by the National Institutes of Health. The CDCs, manufactured by Capricor Inc. (NASDAQ: CAPR) as their product CAP-1002, have been used in other human clinical trials. The ... 41% 14 Aug 17 Beta-cryptoxanthin, a carotenoid, inhibits nicotine-linked lung cancer development in mice New study finds that beta-cryptoxanthin, a carotenoid primarily found in plants, reduces lung cancer development and invasiveness in mouse and cell models. The results support human epidemiological studies associating ... 41% 01 Nov 16 Cell therapy improves heart function, upper limb strength in duchenne muscular dystrophy ... patients were contained in CAP-1002, the lead investigational therapy under development at Capricor Therapeutics, Inc. (NASDAQ: CAPR). "This is the first trial to test cell therapy to treat heart ... 37% 22 Apr 21 Pioneering investigators in experimental heart stem cell and cancer therapies recognized ... of Defense. The stem cells used in his research are manufactured by Capricor Inc. (NASDAQ: CAPR) as their product CAP-1002 and have been used in numerous human clinical trials ... 37% 03 Apr 17 Cedars-Sinai wins $7.3M grant to further study heart stem cell therapy safety, .. ... CDCs to be used in the upcoming study are manufactured by Capricor Therapeutics, Inc. (NASDAQ: CAPR), which is developing this technology as its therapeutic product candidate CAP-1002. "We have ... 33% 06 Dec 16 Veterans among first to get investigational cell therapy under $10m Dept. of Defense grant Building on the results of a recent Cedars-Sinai Heart Institute study published just six months ago, the Department of Defense has awarded a $10 million grant to fund a cardiac cell therapy trial for patients diagnosed ... 33% 03 Oct 16
Market Data 
Markets 
AI
